NASDAQ:SPPI
Delisted

Spectrum Pharmaceuticals Stock News

etoro logo Buy SPPI
*Your capital is at risk
$1.03
+0 (+0%)
At Close: Oct 30, 2023

Spectrum's Big Approval: Any Day Now

05:00am, Thursday, 29'th Jul 2021
Spectrum's Big Approval: Any Day Now
Investors need to pay close attention to for Spectrum Pharmaceuticals (SPPI) stock based on the movements in the options market lately.
HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI--Spectrum Pharmaceuticals (SPPI) to participate in the Jefferies and JMP Securities investor conferences in June.
Rolontis approval was delayed due to Covid-19 and the FDA's inability to inspect its Korean manufacturing facility. The FDA plans to inspect the Hanmi facility this month.
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Joe Turgeon on Q1 2021 Results - Earnings Call Transcript
Spectrum Pharmaceuticals, Inc.'s (SPPI) CEO Joe Turgeon on Q4 2020 Results - Earnings Call Transcript
HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI #earnings--Spectrum Pharmaceuticals Reports Fourth Quarter 2020 and Full Year 2020 Financial Results and Pipeline Update
HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI--Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
The stock price of Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) has increased by over 20% pre-market. This is why it happened.

Spectrum Pharma Is Down But Not Out

10:00am, Monday, 16'th Nov 2020
Spectrum Pharma is down due to two resolvable issues. If the Rolontis PDUFA issue is resolved, the stock may shoot up.
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Joe Turgeon on Q3 2020 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE